Analysis and stability of the constituents of St. John's wort oils prepared with different methods

Journal of Pharmaceutical and Biomedical Analysis

Volumn 45, Issue 5, 2007, Pages 756-761

  Isacchi, B ^a   Bergonzi, M C ^a   Carnevali, F ^b   van der Esch, S A ^b   Vincieri, F F ^a   Bilia, A R ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b ENEA C R CASACCIA   (Italy)

Author keywords

Content variability; Extraction procedures; Harvesting time; St. John's wort oil; Stability

Indexed keywords

ADHYPERFORIN; APIGENIN; FUROHYPERFORIN; HYPERFORIN; HYPERICIN; HYPERICUM PERFORATUM EXTRACT; HYPERIN; OXIHYPERFORIN; PHLOROGLUCINOL; PSEUDOHYPERICIN; QUERCITRIN; RUTOSIDE; UNCLASSIFIED DRUG;

ARTICLE; BURN; CONCENTRATION (PARAMETERS); DRUG ISOLATION; DRUG STABILITY; FLOWER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERICUM PERFORATUM; MASS SPECTROMETRY; PRIORITY JOURNAL; SKIN ULCER; SUNLIGHT; TRADITIONAL MEDICINE;

CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; FREEZING; HYPERICUM; MASS SPECTROMETRY; PLANT EXTRACTS; PLANT OILS; PLANTS, MEDICINAL; TEMPERATURE; TIME FACTORS;

EID: 36148952546     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.08.025     Document Type: Article

References (23)

1. Bradley P., and John's wort St. British Herbal Compendium vol. 2 (2006), British Herbal Medicine Association, Bournemouth, UK pp. 363-368
2. Hyperici Herba. German Commission E Monograph published in: Bundesanzeiger n. 228 of 5 December 1984, amended in Bundesanzeiger of 13 March 1990.
3. Maisenbacher P., and Kovar K.-A. Planta Med. 58 (1992) 351-354
4. Hölzl J. Z Phythotherapie 14 (1993) 255-264
5. ESCOP "Hyperici Herba" Monographs on the Medicinal Uses of Plant Drugs. European Scientific Cooperative on Phytotherapy, Exeter, U.K., 1997.
6. Müller H.J., and Volz H.P. Drugs 52 (1996) 625-638
7. Müller W.E., Rolli M., Schäfer C., and Hafner U. Pharmacopsychiatry 30 (1997) 102-107
8. Chatterjee S.S., Bhattacharya S.K., Wonnemann M., Singer A., and Müller W.E. Life Sci. 63 (1998) 499-510
9. Butterwechk V., Wall A., Liefländer-Wulf U., Winterhoff H., and Nahrstedt A. Pharmacopsychiatry 30 (1997) 117-124
10. Bilia A.R., Gallori S., and Vincieri F.F. Life Sci. 70 (2002) 3077-3096
11. DAB 6 (EB-6) Supplement to Deutsches Arzneibuch. sixth ed. (1953), Deutscher Apotheker Verlag, Berlin p. 366
12. Miraldi E., Biagi M., and Giachetti D. NPC 1 (2006) 209-213
13. Schempp C.M., Winghofer B., Lüdtke R., Simon-Haarhaus B., Schöpf E., and Simon J.C. Br. J. Dermatol. 142 (2000) 979-984
14. Schempp C.M., Hezel S., and Simon C. Hautarzt 54 (2003) 248-253
15. Lomagno P., and Lomagno R.C. Fitoterapia 50 (1979) 201-205
16. Lavagna S.M., Secci D., Chimenti P., Bonsignore L., Ottavini A., and Bizzarri B. Il Farmaco 56 (2001) 451-453
17. Verotta L., Appendino G., Jakupovic J., and Bombardelli E. J. Nat. Prod. 63 (2000) 412-415
18. Gurevich A.I., Dobrynin V.N., Kolosov M.N., Popravko S.A., Ryabova I.D., Chernov B.K., Derbentseva N.A., Aizenman B.E., and Gargulya A.D. Antibiotiki 16 (1971) 510-513
19. Schempp C.M., Kirkin V., Simon-Haarhaus B., Kersten A., Kiss J., Termeer C.C., Gilb B., Kaufmann T., Borner C., Sleeman J.P., and Simon J.C. Oncogene 21 (2002) 1242-1250
20. Schempp C.M., Pelz K., Wittmer A., Schöpf E., and Simon J.C. Lancet 353 (1999) 2129
21. Reichling J., Weseler A., and Saller R. Pharmacopsychiatry 34 (2001) 116-118
22. Albert D., Zündorf I., Dingermann T., Müller W.E., Steinhilber D., and Werz O. Biochem. Pharmacol. 64 (2002) 1767-1775
23. Brolis M., Gabetta B., Fuzzati N., Pace R., Panzeri F., and Peterlongo F. J. Chromatogr. A 825 (1998) 9-16